How much is the Fetal Bovine Serum Market market?

The fetal bovine serum market market size is estimated to grow at $$ 294.16 mn in 2023. Read More

What is the growth rate of the Fetal Bovine Serum Market market?

The growth rate of the fetal bovine serum market year-over-year is 5.25%. Read More

Which region held the largest market share in the Fetal Bovine Serum Market market?

North America is the region to held the largest market share with 38% growth. Read More

Who are the key players in the Fetal Bovine Serum Market market?

Animal Technologies Inc., Atlas Biologicals Inc., Bio Techne Corp., Corning Inc., Danaher Corp., GeminiBio, GeneTex Inc., Grifols SA, HiMedia Laboratories Pvt. Ltd., Itoham Yonekyu Holdings .... Read More

Which Segment has the largest market share in the Fetal Bovine Serum Market market?

Application is the segment that has the largest market share in the market. Read More

Fetal Bovine Serum (FBS) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Denmark, China, India - Size and Forecast 2024-2028

Published: Dec 2023
Pages: 169
SKU: IRTNTR73855

Enjoy complimentary customisation on priority with our Enterprise License!

Fetal Bovine Serum (FBS) Market 2024-2028

The Fetal Bovine Serum (FBS) Market size is estimated to grow by USD 294.16 million at a CAGR of 5.25% between 2023 and 2028.

A stem cell has several applications in research and the biopharmaceutical industry. The efficiency of cellular reprogramming for induced pluripotent stem cells contributes to its popularity. Furthermore, it contains a variety of tissue origins, making it better than others, such as human serum. Its numerous uses drive the growth of the FBS market as tissue development requires the use of FBS. Furthermore, FBS has advantages in serum cell culture, such as stem cell differentiation, morphology, cell proliferation and expansion, and clonal efficiency. Such factors are propelling the demand for FBS, which will drive the growth of the fetal bovine serum market during the forecast period

Technavio has segmented the market into Application, End-user, and Geography

The Application segment is classified into biopharmaceuticals, human and animal vaccine, and others
The End-user segment is classified into pharmaceutical and biopharmaceutical companies, contract research organization, and academic and research organization
The Geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Fetal Bovine Serum Market During the Forecast Period?

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global fetal bovine serum market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global fetal bovine serum market 2018 - 2022 ($ million)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Biopharmaceuticals - Market size and forecast 2023-2028
- Exhibit 34: Chart on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Biopharmaceuticals - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Biopharmaceuticals - Year-over-year growth 2023-2028 (%)

6.4 Human and animal vaccine - Market size and forecast 2023-2028
- Exhibit 38: Chart on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Human and animal vaccine - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Human and animal vaccine - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Human and animal vaccine - Year-over-year growth 2023-2028 (%)

6.5 Others - Market size and forecast 2023-2028
- Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Application
- Exhibit 46: Market opportunity by Application ($ million)
- Exhibit 47: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 50: Chart on Comparison by End-user
- Exhibit 51: Data Table on Comparison by End-user

7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
- Exhibit 52: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)

7.4 Contract research organization - Market size and forecast 2023-2028
- Exhibit 56: Chart on Contract research organization - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Contract research organization - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Contract research organization - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Contract research organization - Year-over-year growth 2023-2028 (%)

7.5 Academic and research organization - Market size and forecast 2023-2028
- Exhibit 60: Chart on Academic and research organization - Market size and forecast 2023-2028 ($ million)
- Exhibit 61: Data Table on Academic and research organization - Market size and forecast 2023-2028 ($ million)
- Exhibit 62: Chart on Academic and research organization - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Academic and research organization - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by End-user
- Exhibit 64: Market opportunity by End-user ($ million)
- Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2023-2028 (%)
- Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Denmark - Market size and forecast 2023-2028
- Exhibit 91: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Denmark - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Denmark - Year-over-year growth 2023-2028 (%)

9.9 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 India - Market size and forecast 2023-2028
- Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
- Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
- Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 Animal Technologies Inc.
- Exhibit 115: Animal Technologies Inc. - Overview
- Exhibit 116: Animal Technologies Inc. - Product / Service
- Exhibit 117: Animal Technologies Inc. - Key offerings

12.4 Atlas Biologicals Inc.
- Exhibit 118: Atlas Biologicals Inc. - Overview
- Exhibit 119: Atlas Biologicals Inc. - Product / Service
- Exhibit 120: Atlas Biologicals Inc. - Key offerings

12.5 Bio Techne Corp.
- Exhibit 121: Bio Techne Corp. - Overview
- Exhibit 122: Bio Techne Corp. - Business segments
- Exhibit 123: Bio Techne Corp. - Key offerings
- Exhibit 124: Bio Techne Corp. - Segment focus

12.6 Corning Inc.
- Exhibit 125: Corning Inc. - Overview
- Exhibit 126: Corning Inc. - Business segments
- Exhibit 127: Corning Inc. - Key news
- Exhibit 128: Corning Inc. - Key offerings
- Exhibit 129: Corning Inc. - Segment focus

12.7 Danaher Corp.
- Exhibit 130: Danaher Corp. - Overview
- Exhibit 131: Danaher Corp. - Business segments
- Exhibit 132: Danaher Corp. - Key news
- Exhibit 133: Danaher Corp. - Key offerings
- Exhibit 134: Danaher Corp. - Segment focus

12.8 Grifols SA
- Exhibit 135: Grifols SA - Overview
- Exhibit 136: Grifols SA - Business segments
- Exhibit 137: Grifols SA - Key offerings
- Exhibit 138: Grifols SA - Segment focus

12.9 HiMedia Laboratories Pvt. Ltd.
- Exhibit 139: HiMedia Laboratories Pvt. Ltd. - Overview
- Exhibit 140: HiMedia Laboratories Pvt. Ltd. - Product / Service
- Exhibit 141: HiMedia Laboratories Pvt. Ltd. - Key offerings

12.10 Itoham Yonekyu Holdings Inc.
- Exhibit 142: Itoham Yonekyu Holdings Inc. - Overview
- Exhibit 143: Itoham Yonekyu Holdings Inc. - Business segments
- Exhibit 144: Itoham Yonekyu Holdings Inc. - Key offerings
- Exhibit 145: Itoham Yonekyu Holdings Inc. - Segment focus

12.11 Merck KGaA
- Exhibit 146: Merck KGaA - Overview
- Exhibit 147: Merck KGaA - Business segments
- Exhibit 148: Merck KGaA - Key news
- Exhibit 149: Merck KGaA - Key offerings
- Exhibit 150: Merck KGaA - Segment focus

12.12 PAN Biotech
- Exhibit 151: PAN Biotech - Overview
- Exhibit 152: PAN Biotech - Product / Service
- Exhibit 153: PAN Biotech - Key offerings

12.13 Rocky Mountain Biologicals
- Exhibit 154: Rocky Mountain Biologicals - Overview
- Exhibit 155: Rocky Mountain Biologicals - Product / Service
- Exhibit 156: Rocky Mountain Biologicals - Key offerings

12.14 Sartorius AG
- Exhibit 157: Sartorius AG - Overview
- Exhibit 158: Sartorius AG - Business segments
- Exhibit 159: Sartorius AG - Key news
- Exhibit 160: Sartorius AG - Key offerings
- Exhibit 161: Sartorius AG - Segment focus

12.15 TCS Biosciences Ltd.
- Exhibit 162: TCS Biosciences Ltd. - Overview
- Exhibit 163: TCS Biosciences Ltd. - Product / Service
- Exhibit 164: TCS Biosciences Ltd. - Key offerings

12.16 Thermo Fisher Scientific Inc.
- Exhibit 165: Thermo Fisher Scientific Inc. - Overview
- Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 167: Thermo Fisher Scientific Inc. - Key news
- Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus

12.17 Tissue Culture Biologicals
- Exhibit 170: Tissue Culture Biologicals - Overview
- Exhibit 171: Tissue Culture Biologicals - Product / Service
- Exhibit 172: Tissue Culture Biologicals - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 173: Inclusions checklist
- Exhibit 174: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 175: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 176: Research methodology
- Exhibit 177: Validation techniques employed for market sizing
- Exhibit 178: Information sources